CALC

1.2607.69%
EW

Eric W. Roberts

Chief Business Officer & Vice Chairman of the Board

Mr. Eric W. Roberts is Director of Graybug Vision, Inc. from February 5, 2023. He is a Founder, Managing Partner and Managing Director at Valence Life Sciences since January 2012 & 2017 respectively. Mr. Roberts is Chief Business Officer and Director at CalciMedica, Inc., since May 2020 and serves as Vice Chairman of the Board since May 2020. Mr. Roberts has been a founding member of Valence Helix Investments. Since June 2006, Mr. Roberts has been a founding Managing Director of Caxton Advantage Venture Partners and co-founded it in 2004. From 2000 to 2003, he served as the Managing Director and Co-Head of the Global Healthcare Investment Banking Group at Lehman Brothers. He served as the Head of Life Sciences Investment Banking at UBS and Dillon, Read & Co. Inc. He was the Founder, Managing Director and Partner of the Life Sciences Department at Dillon, Read & Co. Inc., where he worked from 1986 to 2004. At UBS, he ran the Life Sciences investment banking team. From 1986 to 1989, he served as an Associate in the venture capital and mergers group at CitiCorp Investment Bank. Mr. Roberts worked at Citicorp in the Citicorp Venture Capital (CVC) group before Dillon Read. He is a Board Observer of Regado Biosciences. He served as a Director of VIVUS Inc. since September 15, 2015 until October 22, 2019. He was an Independent Director of Invuity, Inc. since June 2012 until October 22, 2018. He serves on the board of directors of Chinook Pharmaceuticals. He served as a Director of Gemin X Pharmaceuticals, Inc. He has experience in the life sciences industry. He has experience as an Investment Banker and venture capitalist in the healthcare industry. Mr. Roberts received a B.S. in Economics from the Wharton School of the University of Pennsylvania in 1986.

Positions